Public Calendar: March 11 - 17, 2018
This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.
Official Name : Scott Gottlieb, M.D., Commissioner of Food and Drugs
Event Date : 03/14/2018 - 03/14/2018
Location : Laurel, MD
Subject : Food Safety Modernization Act: Intentional Adulteration Rule
FDA Participant/Group : STEPHEN OSTROFF; MICHAEL ROGERS; JON-MIKEL WOODY; RYAN NEWKIRK; CAITLIN BOON;
Non FDA Participant/Group : Elizabeth Fawell, Gregory Pritchard, Matthew Carpenter, Maxine Blanck, Molly Fogarty, Rafaela Carvalho, Sarah Sunday, William Cooper (Nestle);
Event Date : 03/15/2018 - 03/15/2018
Location : SIlver Spring, MD
Subject : The Office of Minority Health Stakeholders: FDA Priorities and Updates
FDA Participant/Group : DAYLE CRISTINZIO; RICHARDAE ARAOJO; JOVONNI SPINNER;
Non FDA Participant/Group : Several statekholders from minority health;
Official Name : Rachel Sherman, M.D., M.P.H.,, Principal Deputy Commissioner
No Significant Event
Official Name : Anna Abram, Deputy Commissioner for Policy, Planning, Legislation, and Analysis
No Significant Event
Official Name : Mark Abdoo , Acting Deputy Commissioner for Global Regulatory Operations and Policy
No Significant Event
Official Name : Jim Sigg, Deputy Commissioner for Operations
No Significant Event
Official Name : Stephen M. Ostroff, M.D., Deputy Commissioner for Foods and Veterinary Medicine
Event Date : 03/16/2018
Location : Washington, DC
Subject : U.S. Apple Association Committee Meeting: Food Safety Modernization Act
FDA Participant/Group : N/A
Non FDA Participant/Group : Several leaders from industry and the U.S. Apple Association;
Official Name : Melinda Plaisier, Associate Commissioner for Regulatory Affairs
No Significant Event
Official Name : Mary Lou Valdez, M.S.M., Associate Commissioner for International Programs
No Significant Event
Official Name : Jennifer Rodriguez, Acting Associate Commissioner for External Affairs
No Significant Event
Official Name : RADM Denise Hinton , Acting Chief Scientist
No Significant Event
Official Name : Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research
Event Date : 03/14/2018 - 03/14/2018
Location : Washington, DC
Subject : Research!America: 2018 Advocacy Awards Dinner
FDA Participant/Group : N/A
Non FDA Participant/Group : N/A
Official Name : Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research
Event Date : 03/15/2018 - 03/15/2018
Location : Cambridge, MA
Subject : First Annual Boston Society Medical Symposium on Acute Myeloid Leukemia (AML): FDA Work to Expedite the Development of Products to Address Serious and Life-Threatening Conditions
FDA Participant/Group : N/A
Non FDA Participant/Group : Stakeholders from industry, academia, medical and science communities
Official Name : Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health
No Significant Event
Official Name : Susan T. Mayne Ph.D., Director, Center for Food Safety and Applied Nutrition
No Significant Event
Official Name : Mitchell R. Zeller, J.D., Director, Center for Tobacco Products
No Significant Event
Official Name : William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research
Event Date : 03/11/2018 - 03/15/2018
Location : San Antonio, TX
Subject : Society of Toxicology 57th Annual Meeting
FDA Participant/Group : N/A
Non FDA Participant/Group : N/A
Official Name : Rebecca K. Wood, J.D., Chief Counsel
No Significant Event